Alejandro Gabriel Vallejos Olivos

Prof. Alejandro Gabriel Vallejos Olivos

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Laboratory Investigation
Verified
Journal Article
Closed access
SGSebastian Gatica
Sebastian Gatica
VVVicente Villegas
Vicente Villegas
AOAlejandro Gabriel Vallejos Olivos
Alejandro Gabriel Vallejos Olivos
POPedro Olivares
Pedro Olivares
VAVíctor Aballai
Víctor Aballai
FSFelipe Simon
Felipe Simon

1 August 2019 in Laboratory Investigation
Verified
Journal Article
Closed access
PDF file
AOAlejandro Gabriel Vallejos Olivos
Alejandro Gabriel Vallejos Olivos
POPedro Olivares
Pedro Olivares
SGSebastian Gatica
Sebastian Gatica
VVVicente Villegas
Vicente Villegas
CECesar Echeverria
Cesar Echeverria
FSFelipe Simon
Felipe Simon

27 January 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
ABAlvaro Becerra
Alvaro Becerra
FSFelipe Eduardo Soto
Felipe Eduardo Soto
AOAlejandro Gabriel Vallejos Olivos
Alejandro Gabriel Vallejos Olivos
DMDaniela Millán
Daniela Millán
JVJuan Jose Valenzuela
Juan Jose Valenzuela
MCManuel E Cortés
Manuel E Cortés
Background: Parthenocissus quinquefolia (Virginia creeper), widely distributed and used in Chile, lacks a systematic characterization of its bioactive components. This study synthesizes the evidence on the phytochemical composition and biological activities of P. quinquefolia, with emphasis on metabolites involved in redox regulation and inflammation. Methods: A systematic review was conducted following PRISMA 2020 guidelines. Searches were performed across four electronic databases, including original studies reporting antioxidant and anti-inflammatory effects. Results: Of 665 records identified, 14 studies met the inclusion criteria. Phytochemical analyses revealed phenolic compounds, particularly flavonoids (e.g., catechin, epicatechin, gallocatechin, epigallocatechin, quercetin, rutin, isoquercitrin, myricetin, luteolin, naringin) and stilbenes (e.g., ε-viniferin, miyabenol C). These metabolites exhibit antioxidant activity through ROS scavenging, metal chelation, and Nrf2/ARE activation. Anti-inflammatory effects were attributed to the downregulation of NF-κB, AP-1, and MAPK signaling, inhibition of NLRP3 inflammasome activation, and suppression of COX-2/iNOS expression. Conclusions: P. quinquefolia is a rich source of phenolic metabolites with robust antioxidant and anti-inflammatory mechanisms. The consistency of molecular responses across studies highlights its potential as a promising candidate for phytotherapeutic development targeting oxidative stress and inflammatory pathways.

15 June 2026 in Journal of Infection and Public Health
Verified
Journal Article
Open access
ABAlvaro Becerra
Alvaro Becerra
NRNicolás Rebolledo
Nicolás Rebolledo
FSFelipe Eduardo Soto
Felipe Eduardo Soto
JVJuan José Valenzuela-Fuenzalida
Juan José Valenzuela-Fuenzalida
JLJessica Paola Loaiza-Giraldo
Jessica Paola Loaiza-Giraldo
Jose Leon-RojasJose Leon-Rojas
Jose Leon-Rojas
Sepsis-induced neuromuscular dysfunction (SIND) is a common but underrecognized complication in critically ill patients, contributing to prolonged intensive care unit (ICU) stays, increased morbidity, and long-term functional impairment. Its pathophysiology is multifactorial, involving interactions among host factors, disease severity, and therapeutic interventions. To systematically identify and classify risk factors associated with SIND in septic patients and to estimate its pooled prevalence across clinical studies. A systematic review and meta-analysis were conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42024577234). Databases; Medline, BMC, Cochrane Library, and Google Scholar, were searched for relevant studies. Fourteen studies including 596 adult patients with sepsis were eligible. Risk factors were categorized into seven clinical domains and further stratified as modifiable or non-modifiable. Pooled prevalence estimates were calculated using a random-effects model (DerSimonian-Laird method). A total of 40 clinical parameters were identified and grouped into seven categories: baseline characteristics, organ failure, disease severity indices, medical procedures, plasma biomarkers, pharmacological therapy, and length of stay. The pooled prevalence of SIND was 60% (95% CI: 50-70%), with substantial heterogeneity. ICU-acquired neuromuscular dysfunction showed a prevalence of 70% (95% CI: 60-80%), whereas direct neuromuscular damage attributable to sepsis was lower (9%, 95% CI: 4-19%). Critical illness polyneuropathy was the most frequently reported entity and demonstrated strong associations with both modifiable and non-modifiable risk factors. SIND is a highly prevalent and multifactorial complication of sepsis. Early recognition of risk factors-particularly modifiable ones-may support targeted preventive strategies and improve clinical outcomes in critically ill patients.